Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-09

Clinical Trial Update: Use of F-652 in Patients With Alcoholic Hepatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for F-652 in alcoholic hepatitis (Phase 1/Phase 2); study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • F-652

Snippet

Sponsor: Mayo Clinic | Conditions: Alcoholic Hepatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-09-09